CHR announces roundtable discussion topic at Reuters Events: Pharma 2023
Following on from our blog earlier in March, we’re thrilled to announce our roundtable topic for Reuters Events: Pharma 2023 – Stand out or lose out – rethinking differentiation in pharma
As efficacy and safety thresholds are becoming tougher to beat and the value proposition of new drugs is less apparent than before, we’re seeing an increasing demand from our clients for assistance in creating differentiation in the market.
But what is the right and most impactful way to do this?
Correctly designed clinical trials?
Targeting a niche segment?
A well-funded marketing campaign?
A clear ESG commitment?
A more patient-centric value proposition?
All of the above? Or more?
Our seasoned CHR consultants will be leading a stimulating discussion about how Pharma must think afresh to differentiate their products, drive choice and ensure commercial success in the future.
If you’re attending Reuters Events: Pharma 2023 and would like to join the round table, signing up is easy. Two weeks before the event, the “Event App” will launch, then it’s a simple registration through the app to secure your place.
If you’re not attending, but are interested in knowing the outcome, be sure to sign up for our mailing list here to receive a copy of the findings.
If you’re interested in arranging a meeting with us beforehand, please get in touch with one of the team members who are attending:
Stephen Galt, CCO
Stephen Godwin, Strategic Advisor to Vox.Bio
Maria Zygouropoulou, Senior Consultant
Roksi Yafet, Research Manager
Constance Ito, Consultant
You can find us at Stand 36! See you there!